IL-11 regulates autoimmune demyelination

Journal of Immunology

Volumn 183, Issue 7, 2009, Pages 4229-4240

  Gurfein, Blake T ^a   Zhang, Yueting ^a   López, Carolina B ^a   Argaw, Azeb Tadesse ^a   Zameer, Andleeb ^a   Moran, Thomas M ^a   John, Gareth R ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P 15095; INTERLEUKIN 11 RECEPTOR ALPHA; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; RECOMBINANT INTERLEUKIN 11; AUTACOID; AUTOANTIBODY; IL11 PROTEIN, HUMAN; IL11RA1 PROTEIN, MOUSE; INTERLEUKIN 11; NEUROPROTECTIVE AGENT;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CELL CULTURE; CLINICAL FEATURE; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEMYELINATING DISEASE; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; EFFECTOR CELL; ENCEPHALOMYELITIS; HISTOPATHOLOGY; IMMUNOREGULATION; LYMPHOCYTE SUBPOPULATION; MALE; MITOSIS; MOUSE; NERVE CELL DEGENERATION; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; STEM CELL; T LYMPHOCYTE ACTIVATION; ALLERGIC ENCEPHALOMYELITIS; AMINO ACID SEQUENCE; ANIMAL; ANTIGEN PRESENTING CELL; BIOSYNTHESIS; C57BL MOUSE; GENETICS; HOSPITALIZATION; HUMAN; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TISSUE CULTURE TECHNIQUE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD11C; AUTOANTIBODIES; COCULTURE TECHNIQUES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-11; INTERLEUKIN-11 RECEPTOR ALPHA SUBUNIT; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; NEUROPROTECTIVE AGENTS; OLIGODENDROGLIA; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; STEM CELLS; TISSUE CULTURE TECHNIQUES;

EID: 70449725291     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900622     Document Type: Article

References (48)

1. Keegan, B. M., and J. H. Noseworthy. 2002. Multiple sclerosis. Annu. Rev. Med. 53: 285-302.
2. Hauser, S. L., and J. R. Oksenberg. 2006. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 52: 61-76. (Pubitemid 44466355)
3. Ridet, J. L., S. K. Malhotra, A. Privat, and F. H. Gage. 1997. Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci. 20: 570-577.
4. Bruck, W., and C. Stadelmann. 2005. The spectrum of multiple sclerosis: new lessons from pathology. Curr. Opin. Neurol. 18: 221-224. (Pubitemid 40813746)
5. Prineas, J. W., R. O. Barnard, E. E. Kwon, L. R. Sharer, and E. S. Cho. 1993. Multiple sclerosis: remyelination of nascent lesions. Ann. Neurol. 33: 137-151. (Pubitemid 23039922)
6. Smith, K. J., W. F. Blakemore, and W. I. McDonald. 1981. The restoration of conduction by central remyelination. Brain 104: 383-404.
7. Bush, T. G., N. Puvanachandra, C. H. Horner, A. Polito, T. Ostenfeld, C. N. Svendsen, L. Mucke, M. H. Johnson, and M. V. Sofroniew. 1999. Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron 23: 297-308.
8. Faulkner, J. R., J. E. Herrmann, M. J. Woo, K. E. Tansey, N. B. Doan, and M. V. Sofroniew. 2004. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J. Neurosci. 24: 2143-2155.
9. John, G. R., S. L. Shankar, B. Shafit-Zagardo, A. Massimi, S. C. Lee, C. S. Raine, and C. F. Brosnan. 2002. Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat. Med. 8: 1115-1121.
10. Zhang, Y., C. Taveggia, C. Melendez-Vasquez, S. Einheber, C. S. Raine, J. L. Salzer, C. F. Brosnan, and G. R. John. 2006. Interleukin-11 potentiates oligodendrocyte survival and maturation, and myelin formation. J. Neurosci. 26: 12174-12185. (Pubitemid 44808384)
11. Butzkueven, H., J. G. Zhang, M. Soilu-Hanninen, H. Hochrein, F. Chionh, K. A. Shipham, B. Emery, A. M. Turnley, S. Petratos, M. Ernst, et al. 2002. LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival. Nat. Med. 8: 613-619. (Pubitemid 34633440)
12. Linker, R. A., M. Maurer, S. Gaupp, R. Martini, B. Holtmann, R. Giess, P. Rieckmann, H. Lassmann, K. V. Toyka, M. Sendtner, and R. Gold. 2002. CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation. Nat. Med. 8: 620-624.
13. Goldman, S. J. 1995. Preclinical biology of interleukin 11: a multifunctional hematopoietic cytokine with potent thrombopoietic activity. Stem Cells 13: 462-471.
14. Trepicchio, W. L., L. Wang, M. Bozza, and A. J. Dorner. 1997. IL-11 regulates macrophage effector function through the inhibition of nuclear factor-κB. J. Immunol. 159: 5661-5670.
15. Weich, N. S., A. Wang, M. Fitzgerald, T. Y. Neben, D. Donaldson, J. Giannotti, J. Yetz-Aldape, R. M. Leven, and K. J. Turner. 1997. Recombinant human interleukin-11 directly promotes megakaryocytopoiesis in vitro. Blood 90: 3893-3902.
16. Mehler, M. F., R. Rozental, M. Dougherty, D. C. Spray, and J. A. Kessler. 1993. Cytokine regulation of neuronal differentiation of hippocampal progenitor cells. Nature 362: 62-65.
17. Nandurkar, H. H., L. Robb, D. Tarlinton, L. Barnett, F. Kontgen, and C. G. Begley. 1997. Adult mice with targeted mutation of the interleukin-11 receptor (IL11Ra) display normal hematopoiesis. Blood 90: 2148-2159.
18. Robb, L., R. Li, L. Hartley, H. H. Nandurkar, F. Koentgen, and C. G. Begley. 1998. Infertility in female mice lacking the receptor for interleukin 11 is due to a defective uterine response to implantation. Nat. Med. 4: 303-308. (Pubitemid 28144088)
19. -/- mice: evidence for loss of apoptotic activity in lymphocytes. J. Immunol. 176: 3115-3126.
20. Brosnan, C. F., E. A. Goldmuntz, W. Cammer, S. M. Factor, B. R. Bloom, and W. T. Norton. 1985. Prazosin, an α1-adrenergic receptor antagonist, suppresses experimental autoimmune encephalomyelitis in the Lewis rat. Proc. Natl. Acad. Sci. USA 82: 5915-5919.
21. Caporaso, G. L., and M. V. Chao. 2001. Telomerase and oligodendrocyte differentiation. J. Neurobiol. 49: 224-234.
22. Yount, J. S., T. A. Kraus, C. M. Horvath, T. M. Moran, and C. B. Lopez. 2006. A novel role for viral-defective interfering particles in enhancing dendritic cell maturation. J. Immunol. 177: 4503-4513.
23. Argaw, A. T., Y. Zhang, B. J. Snyder, M. L. Zhao, N. Kopp, S. C. Lee, C. S. Raine, C. F. Brosnan, and G. R. John. 2006. IL-1β regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program. J. Immunol. 177: 5574-5584.
24. Sternberger, L. A., and N. H. Sternberger. 1983. Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ. Proc. Natl. Acad. Sci. USA 80: 6126-6130.
25. Robb, L., D. J. Hilton, P. T. Brook-Carter, and C. G. Begley. 1997. Identification of a second murine interleukin-11 receptor α-chain gene (IL11Ra2) with a restricted pattern of expression. Genomics 40: 387-394. (Pubitemid 27136990)
26. Barres, B. A., M. C. Raff, F. Gaese, I. Bartke, G. Dechant, and Y. A. Barde. 1994. A crucial role for neurotrophin-3 in oligodendrocyte development. Nature 367: 371-375. (Pubitemid 24062343)
27. Komiyama, Y., S. Nakae, T. Matsuki, A. Nambu, H. Ishigame, S. Kakuta, K. Sudo, and Y. Iwakura. 2006. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177: 566-573. (Pubitemid 43939170)
28. Vaknin-Dembinsky, A., K. Balashov, and H. L. Weiner. 2006. IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production. J. Immunol. 176: 7768-7774. (Pubitemid 43849078)
29. Banchereau, J., J. Fay, V. Pascual, and A. K. Palucka. 2003. Dendritic cells: controllers of the immune system and a new promise for immunotherapy. Novartis Found. Symp. 252: 226-235; discussion 235-228: 257-267.
30. Mellman, I., and R. M. Steinman. 2001. Dendritic cells: specialized and regulated antigen processing machines. Cell 106: 255-258. (Pubitemid 32772607)
31. Steinman, R. M., G. Kaplan, M. D. Witmer, and Z. A. Cohn. 1979. Identification of a novel cell type in peripheral lymphoid organs of mice. V. Purification of spleen dendritic cells, new surface markers, and maintenance in vitro. J. Exp. Med. 149: 1-16.
32. Heinrich, P. C., I. Behrmann, S. Haan, H. M. Hermanns, G. Muller-Newen, and F. Schaper. 2003. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 374: 1-20.
33. Ernst, M., and B. J. Jenkins. 2004. Acquiring signalling specificity from the cytokine receptor gp130. Trends Genet. 20: 23-32. (Pubitemid 38032817)
34. Di Marco, R., M. Khademi, E. Wallstrom, E. Iacobaeus, A. Salvaggio, S. Caracappa, R. Papoian, F. Nicoletti, and T. Olsson. 2001. Curative effects of recombinant human interleukin-6 in DA rats with protracted relapsing experimental allergic encephalomyelitis. J. Neuroimmunol. 116: 168-177. (Pubitemid 32588629)
35. Samoilova, E. B., J. L. Horton, B. Hilliard, T. S. Liu, and Y. Chen. 1998. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. J. Immunol. 161: 6480-6486. (Pubitemid 28562184)
36. Steinman, L. 2004. Elaborate interactions between the immune and nervous systems. Nat. Immunol. 5: 575-581. (Pubitemid 38811881)
37. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, and V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
38. Veldhoen, M., R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger. 2006. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179-189. (Pubitemid 43214587)
39. Kuhlmann, T., L. Remington, I. Cognet, L. Bourbonniere, S. Zehntner, F. Guilhot, A. Herman, A. Guay-Giroux, J. P. Antel, T. Owens, and J. F. Gauchat. 2006. Continued administration of ciliary neurotrophic factor protects mice from inflammatory pathology in experimental autoimmune encephalomyelitis. Am. J. Pathol. 169: 584-598.
40. Musashi, M., Y. C. Yang, S. R. Paul, S. C. Clark, T. Sudo, and M. Ogawa. 1991. Direct and synergistic effects of interleukin 11 on murine hemopoiesis in culture. Proc. Natl. Acad. Sci. USA 88: 765-769.
41. Paul, S. R., F. Bennett, J. A. Calvetti, K. Kelleher, C. R. Wood, R. M. O'Hara, Jr., A. C. Leary, B. Sibley, S. C. Clark, D. A. Williams, et al. 1990. Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc. Natl. Acad. Sci. USA 87: 7512-7516.
42. Tepler, I., L. Elias, J. W. Smith II, M. Hussein, G. Rosen, A. Y. Chang, J. O. Moore, M. S. Gordon, B. Kuca, K. J. Beach, et al. 1996. A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy. Blood 87: 3607-3614.
43. Takeuchi, Y., S. Watanabe, G. Ishii, S. Takeda, K. Nakayama, S. Fukumoto, Y. Kaneta, D. Inoue, T. Matsumoto, K. Harigaya, and T. Fujita. 2002. Interleukin-11 as a stimulatory factor for bone formation prevents bone loss with advancing age in mice. J. Biol. Chem. 277: 49011-49018.
44. Sonis, S. T., A. G. Van Vugt, J. McDonald, E. Dotoli, U. Schwertschlag, P. Szklut, and J. Keith. 1997. Mitigating effects of interleukin 11 on consecutive courses of 5-fluorouracil-induced ulcerative mucositis in hamsters. Cytokine 9: 605-612.
45. Yucel, O. O., E. Berker, S. Gariboglu, and H. Otlu. 2008. Interleukin-11, interleukin-1β, interleukin-12 and the pathogenesis of inflammatory periodontal diseases. J. Clin. Periodontol. 35: 365-370.
46. Hauser, S. L., T. H. Doolittle, R. Lincoln, R. H. Brown, and C. A. Dinarello. 1990. Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6. Neurology 40: 1735-1739.
47. Steinman, L. 2008. Nuanced roles of cytokines in three major human brain disorders. J. Clin. Invest. 118: 3557-3563.
48. Linthicum, D. S., J. J. Munoz, and A. Blaskett. 1982. Acute experimental autoimmune encephalomyelitis in mice. I. Adjuvant action of Bordetella pertussis is due to vasoactive amine sensitization and increased vascular permeability of the central nervous system. Cell. Immunol. 73: 299-310.